Studies stress symptoms in women treated with internal radiation for cervical cancer
Tracks stress symptoms in women with cervical cancer after internal radiation.
Plain-language title generated from the registry record
Registry title: Post-TRaUmatic STress Disorder Induced by Gynecological Brachytherapy
Key facts
- Where
- Pierre-Bénite and Strasbourg, FranceSee the 2 sites
Where in France
- Groupement Hospitalier Sud - Hopital Lyon SudPierre-Bénite, FranceTaking people
- ICANSStrasbourg, FranceTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Centre Paul Strauss
- Trial code
- NCT07204535
- Record updated
- 4 June 2026
- Original description
This is a multicenter, prospective study aimed at providing information on the psychological effects (including post-traumatic stress symptoms) of utero-vaginal brachytherapy in patients with cervical cancer using self-administered questionnaires. The study also aims to assess the persistence of these symptoms over time, up to 5 years after brachytherapy. The results could help identify patients at risk of post-traumatic stress in this context and develop appropriate psychological interventions to improve their psychological well-being during and after treatment.Read full original descriptionShow less
Post-TRaUmatic STress Disorder Induced by Gynecological Brachytherapy
This is a multicenter, prospective study aimed at providing information on the psychological effects (including post-traumatic stress symptoms) of utero-vaginal brachytherapy in patients with cervical cancer using self-administered questionnaires. The study also aims to assess the persistence of these symptoms over time, up to 5 years after brachytherapy. The results could help identify patients at risk of post-traumatic stress in this context and develop appropriate psychological interventions to improve their psychological well-being during and after treatment.
Inclusion: Confirmed diagnosis of cervical cancer with an indication for High-dose rate (HDR) or pulse-dose rate (PDR) uterovaginal brachytherapy; Squamous cell carcinoma or other histological types; WHO ≤ 2; Ability to complete validated questionnaires in French; Informed consent to participate in the study; Patients over 18 years old.
Exclusion: Inability to understand or respond to questionnaires due to a cognitive disorder, intellectual disability, language barrier, or psychiatric disorder that impairs judgment; Patient under juridic protection; Pregnant or breastfeeding woman.